Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Major depression disorder (MDD) or depression is highly prevalent in diabetic patients, where the depressive symptoms are more severe and less responsive to antidepressant therapies. The underlying mechanism is little understood. We hypothesized that the pathophysiology of comorbid depression was more complex than that proposed for MDD and that neural cell death played a role in the disease severity. To test this hypothesis, we generated streptozotocin (STZ)-induced diabetic mice. These mice had blood glucose 3 fold above controls and exhibited depressive phenotypes as judged by a battery of behavioral tests, thus confirming the comorbidity in mice. Immunohistological studies showed markedly increased TUNEL positive cells in the frontal cortex and hippocampus of the comorbid mice. The apoptosis were supported by increased caspase-3 and decreased Bcl-2 proteins in the brain regions. In addition, the serum BDNF level of comorbid mice was reduced, further supporting the neurodenerative change. Mechanistic analyses showed an increased expression of mitochondrial fission genes fission protein 1 (Fis1) and dynamin-related protein 1 (Drp1) and a decreased expression of mitochondrial fusion genes mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), and optical atrophy 1 (Opa1). Representative assessment of proteins Drp1 and Mfn2 mirrored the mRNA changes. The data demonstrated that neural cell death was associated with the depressive phenotype of comorbid mice and that a fission-dominant expression of genes and proteins mediating mitochondrial dynamics played a role in the hyperglycemia-induced cell death. The study provides new insight into the disease mechanism and may lend evidence of developing novel therapeutics aiming at neuroprotection by modulating mitochondrial dynamics to treat comorbid depression with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 5×
“The historical monoamine hypothesis postulates a decreased monoamine function in the brain (Krishnan and Nestler, 2008); the neurotrophic hypothesis proposes a decrement of brainderived neurotrophic factor (BDNF), a neurotrophic factor that is key to modulating neuroplasticity in the adult brain…”
InfluentialRisk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · cited 1×
“Second, large-scale and longitudinal studies have shown that diabetes increases the rate of developing dementia (Biessels et al., 2006; van Harten et al., 2007), implicating hyperglycemia in neurodegeneration.”
Hippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590 · cited 2×
“Brain imaging studies have documented volume reductions in the hippocampus and other forebrain regions of MDD patients (Videbech and Ravnkilde, 2004; Savitz and Drevets, 2009).”
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 3×
“These proposed molecular disturbances are thought to ultimately alter synaptic plasticity in the hippocampus and cortex, the brain areas thought to be important in regulating affective behaviors (Martinowich et al., 2007; Krishnan and Nestler, 2008; Zunszain et al., 2011; Eisch and Petrik, 2012).”
Cassidy-Stone, A., Chipuk, J. E., Ingerman, E., Song, C., Yoo, C., Kuwana, T., Kurth, M. J., Shaw, J. T., Hinshaw, J. E., Green, D. R., et al. (2008) · Developmental Cell · doi:10.1016/j.devcel.2007.11.019 · Cited by 1,200
Blood BDNF Concentrations Reflect Brain-Tissue BDNF Levels across Species
Klein, A. B., Williamson, R., Santini, M. A., Clemmensen, C., Ettrup, A., Rios, M., Knudsen, G. M., & Aznar, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000738 · Cited by 726 · cited 4×
“TUNEL-positive and DAPI-positive staining patterns were acquired by the Olympus f1000 microscope (Olympus, Japan).”
InfluentialMolendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702 · cited 11×
“They used this model to test whether neural cell death, not generally considered to underlie MDD, contributes to depression in the comorbid mice.”
InfluentialGlucocorticoids, cytokines and brain abnormalities in depression
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.011 · Cited by 554
Animal Models of Depression: Molecular Perspectives
Krishnan, V., & Nestler, E. J. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2010_108 · Cited by 528 · cited 1×
“Depressive phenotypes of the diabetic mice were evaluated in the eighth week of the study by tail-suspension test (TST) and forced swimming test (FST), the most widely used assays to assess antidepressant efficacy in preclinical studies (Krishnan and Nestler, 2011).”
Cited by
The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140
“Pathological isoforms of DISC1 lead to abnormal neuronal development and mood disorders (137).”
BackgroundMitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders?
Culmsee, C., Michels, S., Scheu, S., Arolt, V., Dannlowski, U., & Alferink, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00739 · Cited by 110
Muscle-generated BDNF is a sexually dimorphic myokine that controls metabolic flexibility
Yang, X., Brobst, D., Chan, W. S., Tse, M. C. L., Herlea-Pana, O., Ahuja, P., Bi, X., Zaw, A. M., Kwong, Z. S. W., Jia, W.-H., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aau1468 · Cited by 99
“Although BDNF has not always been successfully detected in mouse serum (39), BDNF serum levels are decreased in streptozotocin-induced diabetic mice and increased in a mouse model of acute asthma (40, 41), suggesting that BDNF is detectable in mouse circulation.”
Background
Metadata
- Authors
- Chen, C., Wang, Y., Zhang, J., Ma, L., Gu, J., & Ho, G.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2014-01-01
- Volume
- 7
- Issue
- 6
- Pages
- 723-30
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2111944869
- Cited by
- 57
- References
- 20
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.